Thomson Reuters saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 68 to 72.
IBD's proprietary rating measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
History reveals that the top-performing stocks tend to have an RS Rating of over 80 in the early stages of their moves. See if Thomson Reuters can continue to show renewed price strength and clear that threshold.
When To Sell Stocks To Lock In Profits And Minimize Losses
Thomson Reuters is in a buy zone after climbing above a 176.03 entry in a flat base. The proper buying range extends to 5% above the initial entry. Once a stock hits that benchmark, it's best to hold off investing and wait for it to set up another buying opportunity..
Earnings growth rose last quarter from -2% to 3%, but revenue fell from 8% to 5%.
The company earns the No. 3 rank among its peers in the Commercial Services-Market Research industry group. Moody's is the top-ranked stock within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
